Findings from EMA ‘PROTECT’ Project are improving benefit-risk monitoring of medicines

The key findings of the PROTECT project (Pharmacoepidemiological Research on Outcomes of Therapeutics by a European Consortium project) have been published.

PROTECT is a collaborative European project that comprises a programme to address limitations of current methods in the field of pharmacoepidemiology and pharmacovigilance. To view a summary of the PROTECT key findings and recommendations document, click here to visit the EMA Website.

The results of the Research on Outcomes of Therapeutics by a European Consortium (PROTECT) project, are making a difference in the assessment of benefits and risks of medicines available for patients in Europe.

To visit the PROTECT website, click here